Scientists in China believe new drug can stop pandemic 'without vaccine'
BEIJING, China — A Chinese laboratory has been developing a drug it believes has the power to bring the coronavirus pandemic to a halt.
The outbreak first emerged in China late last year before spreading across the world, prompting an international race to find treatments and vaccines.
A drug being tested by scientists at China's prestigious Peking University could not only shorten the recovery time for those infected, but even offer short-term immunity from the virus, researchers say.
Sunney Xie, director of the university's Beijing Advanced Innovation Center for Genomics, told AFP that the drug has been successful at the animal testing stage.
"When we injected neutralising antibodies into infected mice, after five days the viral load was reduced by a factor of 2,500," said Xie.
"That means this potential drug has (a) therapeutic effect."
The drug uses neutralising antibodies — produced by the human immune system to prevent the virus infecting cells — which Xie's team isolated from the blood of 60 recovered patients.
A study on the team's research, published Sunday in the scientific journal Cell, suggests that using the antibodies provides a potential "cure" for the disease and shortens recovery time.
Xie said his team had been working "day and night" searching for the antibody.
"Our expertise is single-cell genomics rather than immunology or virology. When we realised that the single-cell genomic approach can effectively find the neutralising antibody we were thrilled."
He said he hopes that the drug will be ready for use later this year and in time for any potential winter outbreak of the virus, which has infected 4.8 million people around the world and killed more than 315,000.
"Planning for the clinical trial is underway," said Xie, adding it will be carried out in Australia and other countries since cases have dwindled in China, offering fewer human guinea pigs for testing.
"The hope is these neutralising antibodies can become a specialised drug that would stop the pandemic," he said.
China already has five potential coronavirus vaccines at the human trial stage, a health official said last week.
But the World Health Organization has warned that developing a vaccine could take 12 to 18 months.
Scientists have also pointed to the potential benefits of plasma — a blood fluid — from recovered individuals who have developed antibodies to the virus enabling the body's defences to attack it.
More than 700 patients have received plasma therapy in China, a process which authorities said showed "very good therapeutic effects".
"However, it (plasma) is limited in supply," Xie said, noting that the 14 neutralising antibodies used in their drug could be put into mass production quickly.
Prevention and cure
Using antibodies in drug treatments is not a new approach, and it has been successful in treating several other viruses such as HIV, Ebola and Middle East Respiratory Syndrome (MERS).
Xie said his researchers had "an early start" since the outbreak started in China before spreading to other countries.
Ebola drug Remdesivir was considered a hopeful early treatment for COVID-19 — clinical trials in the US showed it shortened the recovery time in some patients by a third — but the difference in mortality rate was not significant.
The new drug could even offer short-term protection against the virus.
The study showed that if the neutralising antibody was injected before the mice were infected with the virus, the mice stayed free of infection and no virus was detected.
This may offer temporary protection for medical workers for a few weeks, which Xie said they are hoping to "extend to a few months".
More than 100 vaccines for COVID-19 are in the works globally, but as the process of vaccine development is more demanding, Xie is hoping that the new drug could be a faster and more efficient way to stop the global march of the coronavirus.
"We would be able to stop the pandemic with an effective drug, even without a vaccine," he said.
Follow this page for updates on a mysterious pneumonia outbreak that has struck dozens of people in China.
New Zealand Prime Minister Chris Hipkins says on Sunday that he had contracted COVID-19, testing positive at a key point in his flailing campaign for re-election.
Hipkins saYS on his official social media feed that he would need to isolate for up to five days -- less than two weeks before his country's general election.
The leader of the centre-left Labour Party said he started to experience cold symptoms on Saturday and had cancelled most of his weekend engagements. — AFP
The World Health Organization and US health authorities say Friday they are closely monitoring a new variant of COVID-19, although the potential impact of BA.2.86 is currently unknown.
The WHO classified the new variant as one under surveillance "due to the large number (more than 30) of spike gene mutations it carries", it wrote in a bulletin about the pandemic late Thursday.
So far, the variant has only been detected in Israel, Denmark and the United States. — AFP
The World Health Organization says on Friday that the number of new COVID-19 cases reported worldwide rose by 80% in the last month, days after designating a new "variant of interest".
The WHO declared in May that Covid is no longer a global health emergency, but has warned that the virus will continue to circulate and mutate, causing occasional spikes in infections, hospitalisations and deaths.
In its weekly update, the UN agency said that nations reported nearly 1.5 million new cases from July 10 to August 6, an 80% increase compared to the previous 28 days. — AFP
The head of US intelligence says that there was no evidence that the COVID-19 virus was created in the Chinese government's Wuhan research lab.
In a declassified report, the Office of the Director of National Intelligence (ODNI) says they had no information backing recent claims that three scientists at the lab were some of the very first infected with COVID-19 and may have created the virus themselves.
Drawing on intelligence collected by various member agencies of the US intelligence community (IC), the ODNI report says some scientists at the Wuhan lab had done genetic engineering of coronaviruses similar to COVID-19. — AFP
Boris Johnson deliberately misled MPs over Covid lockdown-breaking parties in Downing Street when he was prime minister, a UK parliament committee ruled on Thursday.
The cross-party Privileges Committee said Johnson, 58, would have been suspended as an MP for 90 days for "repeated contempts (of parliament) and for seeking to undermine the parliamentary process".
But he avoided any formal sanction by his peers in the House of Commons by resigning as an MP last week.
In his resignation statement last Friday, Johnson pre-empted publication of the committee's conclusions, claiming a political stitch-up, even though the body has a majority from his own party.
He was unrepentant again on Thursday, accusing the committee of being "anti-democratic... to bring about what is intended to be the final knife-thrust in a protracted political assassination".
Calling it "beneath contempt", he said it was "for the people of this to decide who sits in parliament, not Harriet Harman", the veteran opposition Labour MP who chaired the seven-person committee. — AFP
- Latest
- Trending
